HIV/AIDS

The latest HIV/AIDS news from UNC Health Care and the UNC School of Medicine.

UNC Study Advances the Ability to Expose Latent HIV

UNC Study Advances the Ability to Expose Latent HIV

UNC researchers led by Nancie Archin, PhD, and David Margolis, MD, have shown that interval dosing of the drug Vorinostat reverses HIV latency and is well-tolerated in people living with HIV. However, while Vorinostat makes latent HIV easier to detect, it does not clear or deplete infection, meaning additional advances will be needed to achieve a cure. These results were published in the Journal of Clinical Investigation on July 17.

UNC Study Advances the Ability to Expose Latent HIV - Read More…

UNC receives $18 million to develop mobile technology to prevent and treat HIV in adolescents

UNC receives $18 million to develop mobile technology to prevent and treat HIV in adolescents

iTech project will target people under the age of 30, the population with most new HIV infections in US. The effort is led by Lisa Hightow-Weidman, MD, MPH, associate professor of medicine.

UNC receives $18 million to develop mobile technology to prevent and treat HIV in adolescents - Read More…

Researchers Discuss Challenges, Successes of HIV Cure Research in Science

Researchers Discuss Challenges, Successes of HIV Cure Research in Science

A better understanding of HIV latency is the key to eradicating the virus researchers at the University of North Carolina and partner institutions write in a perspective in the journal Science.

Researchers Discuss Challenges, Successes of HIV Cure Research in Science - Read More…

HIV Treatment Keeps Uninfected Partner from Contracting the Virus

HIV Treatment Keeps Uninfected Partner from Contracting the Virus

Anti-HIV medications suppress the viral load of people living with HIV and provide durable protection against heterosexual transmission according to the groundbreaking study led by Myron Cohen, MD.

HIV Treatment Keeps Uninfected Partner from Contracting the Virus - Read More…

Infectious Disease Clinic Celebrates Early Heroes

Infectious Disease Clinic Celebrates Early Heroes

A recent gathering in the UNC Infectious Disease Clinic served as a reunion for the nurses and other medical staff who worked tirelessly to care for patients in the early days of the HIV/AIDS epidemic and ultimately led to the establishment of a dedicated clinic within the hospital for those patients.

Infectious Disease Clinic Celebrates Early Heroes - Read More…

 Early Antiretroviral Therapy Protects Sero-Discordant Couples from Transmission of HIV to Their Uninfected Partner

Early Antiretroviral Therapy Protects Sero-Discordant Couples from Transmission of HIV to Their Uninfected Partner

These findings demonstrate that antiretroviral therapy, when taken until viral suppression is achieved and sustained, is a highly effective, durable intervention for HIV prevention.

Early Antiretroviral Therapy Protects Sero-Discordant Couples from Transmission of HIV to Their Uninfected Partner - Read More…

Carolina, GSK announce novel partnership to accelerate search for HIV cure

Carolina, GSK announce novel partnership to accelerate search for HIV cure

The HIV Cure center will be located on the UNC-Chapel Hill campus and will focus exclusively on finding a cure for HIV/AIDS.

Carolina, GSK announce novel partnership to accelerate search for HIV cure - Read More…

Researchers identify timeline for HIV replication in the brain

Researchers identify timeline for HIV replication in the brain

A new study in PLoS Pathogens shows that HIV can infect the brain early on and should be combated as soon as possible with antiretroviral therapy to limit risk of dementia

Researchers identify timeline for HIV replication in the brain - Read More…

Becoming Less Super as a Specialist

Becoming Less Super as a Specialist

Dr. David Wohl, an HIV/AIDS specialist at UNC, reflects on the reasons why he now finds himself drawn to fighting Ebola.

Becoming Less Super as a Specialist - Read More…

Margolis collaboration featured in The New Yorker

Margolis collaboration featured in The New Yorker

UNC School of Medicine researcher David Margolis, MD, was one of the first researchers to resist the common view that HIV is an incurable infection

Margolis collaboration featured in The New Yorker - Read More…

UNC to partner in new global HIV/AIDS project

Supporting Operational AIDS Research (SOAR) is a global research project to determine how best to address challenges and gaps that remain in the delivery of HIV and AIDS care and support, treatment, and prevention services.

UNC to partner in new global HIV/AIDS project - Read More…

UNC receives $1.5 million grant to strengthen HIV/AIDS research training in South Africa

UNC receives $1.5 million grant to strengthen HIV/AIDS research training in South Africa

The University of North Carolina at Chapel Hill has received a $1.5 million grant aimed at strengthening HIV/AIDS research training in collaboration with the Wits School of Public Health at the University of the Witwatersrand in Johannesburg, South Africa.

UNC receives $1.5 million grant to strengthen HIV/AIDS research training in South Africa - Read More…

Several UNC faculty published in JAMA theme issue on HIV/AIDS

Several members of the UNC School of Medicine faculty had articles published in the Journal of the American Medical Association's (JAMA) July 23/30, 2014, HIV/AIDS theme issue.

Several UNC faculty published in JAMA theme issue on HIV/AIDS - Read More…

UNC School of Medicine again ranked highly by U.S. News & World Report

UNC School of Medicine again ranked highly by U.S. News & World Report

The School ranked 2nd in Primary Care and 22nd in Research overall in the 2015 U.S. News & World Report Best Medical School Rankings. Family Medicine, Rural Medicine and AIDS were also listed as top ten specialties.

UNC School of Medicine again ranked highly by U.S. News & World Report - Read More…

UNC receives more than $40 million from NIH for global clinical trials unit to treat and prevent HIV

UNC receives more than $40 million from NIH for global clinical trials unit to treat and prevent HIV

The University of North Carolina at Chapel Hill has received a seven-year, more than $40 million award from the National Institutes of Health for a clinical trials unit that will implement the scientific agendas of five NIH networks devoted to HIV/AIDS treatment, prevention, and cure research.

UNC receives more than $40 million from NIH for global clinical trials unit to treat and prevent HIV - Read More…

Screening new inmates for HIV may not reveal many new undetected cases, study shows

Screening new inmates for HIV may not reveal many new undetected cases, study shows

More than 22,000 inmates entering North Carolina prisons in 2008 and 2009 were tested for HIV, but only 20 new cases of HIV were found.

Screening new inmates for HIV may not reveal many new undetected cases, study shows - Read More…

UNC, Duke Team up with Carrboro-based Caktus Group on HIV Gaming App

UNC, Duke Team up with Carrboro-based Caktus Group on HIV Gaming App

The Daily Dose app will utilize game mechanics and social networking features to improve adherence to HIV medication.

UNC, Duke Team up with Carrboro-based Caktus Group on HIV Gaming App - Read More…

Share This: